Drug intelligence / Profile preview

SCV-SMPOX

Development stage
Preclinical
Lead developer
Sementis
Modality
Viral Vectors → Gene Addition/Replacement → Gene Therapies, Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

SCV-SMPOX is a vaccine candidate developed for the prevention of smallpox and mpox (monkeypox). It is based on a recombinant viral vector platform, specifically using the vaccinia virus as a backbone. The vaccine is designed to induce an immune response against orthopoxviruses, including both variola virus (smallpox) and monkeypox virus. Its mechanism of action involves stimulating both humoral and cellular immunity by presenting orthopoxvirus antigens to the immune system. The primary indication for this vaccine candidate is prophylaxis against smallpox and mpox in at-risk populations.

Brand names
SCV-SMPOX
Other names
SCV-SMPOX
02

Targets

Orthopoxvirus antigens (expressed by Sementis Copenhagen Vector)

Beyond the preview

Go deeper on SCV-SMPOX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCV-SMPOX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call